Thrombosis and risk factors: A comment

Kaynakça (8)

1. Akar N. Thrombosis and risk factors. Turk J Hematol 2010; 27:318-9
2. Yilmaz H, Isbir S, Agachan B, Ergen A, Farsak B, Isbir T. C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease. Cell Biochem Funct. 2006; 24:87-90
3. Carmel R. Megaloblastic Anemias: Disorders of Impaired DNA Synthesis. In: Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber DA, Means RT Jr, eds. Wintrobe’s Clinical Hematology. 12th ed. Philadelphia: Lippincott Williams & Wilkins, 2009: 1143-72
4. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, Johnston C, Engbaek F, Schneede J, McPartlin C, Scott JM. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004; 50(1):3-32
5. Refsum H, Ueland PM, Nygård O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med. 1998; 49:31-62
6. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG; MTHFR Studies Collaboration Group. MTHFR 677C- ->T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA. 2002;288(16):2023-31
7. Akar N: Thrombosis and risk factors. Turk J Hematol 2010: 27 (4): 318-319 2. Koç YL, Akar N: Single nucleotide polymorphisms that affect homocysteine levels in Turkish population. Clin Appl Thromb Hemost 2009; 15: 701-704 3. Lyon E: Discovering rare variants by use of melting temperature shifts seen in melting curve analysis. Clin Chem 2005; 51: 1331-1332 4. Erali M, Schmidt B, Lyon E, Wittwer C: Evaluation of electronic microarrays for genotyping factor V, factor II, and MTHFR. Clin Chem 2003; 49: 732-739 5. Eğin Y, Akar N: First observation of MTHFR 678 C-A (Ala222Ala) single nucleotide polymorphism. Turk J Hematol 2011 (DOI: 10.5152/tjh.2011.45
8. Akar N, Akar E, Misirlioğlu M, Avcu F, Yalçin A, Cin S: Search for genetic factors favoring thrombosis in Turkish population. Thromb Res 1998; 92 (2): 79-82